Chara Papadaki - Concepedia

Author

Chara Papadaki

University of Crete ORCID

Also Known As

C Papadaki, C. Papadaki, CHARA PAPADAKI, Chara Papadaki

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

University of Crete University Hospital of Heraklion Foundation for Research and Technology Hellas Harokopio University of Athens The General Hospital of Heraklion "Venizeleio-Pananio"

About

Chara Papadaki is an author at University of Crete specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	169
2	Cell Biology	5	5	155
3	Pathology	4	4	122
4	Health Sciences	1	1	14
5	Immunology	1	1	14

Chara Papadaki

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Tumor BRCA1, RRM1 and RRM2 mRNA Expression Levels and Clinical Response to First-Line Gemcitabine plus Docetaxel in Non-Small-Cell Lung Cancer Patients Ioannis Boukovinas, Chara Papadaki, Pedro Méndez, PLoS ONE	2008	124
Impact of KRAS, BRAF, PIK3CA Mutations, PTEN, AREG, EREG Expression and Skin Rash in ≥2nd Line Cetuximab-Based Therapy of Colorectal Cancer Patients Zacharenia Saridaki, Maria Tzardi, Chara Papadaki, PLoS ONE	2011	124
Clinical Relevance of Immune Checkpoints on Circulating Tumor Cells in Breast Cancer Maria A. Papadaki, Anastasios Koutsopoulos, Panormitis G Tsoulfas, Cancers	2020	87
Circulating microRNAs in the early prediction of disease recurrence in primary breast cancer Chara Papadaki, Michalis Stratigos, Georgios Markakis, Breast Cancer Research	2018	71
ERCC1 and BRAC1 mRNA Expression Levels in the Primary Tumor Could Predict the Effectiveness of the Second-Line Cisplatin-Based Chemotherapy in Pretreated Patients with Metastatic Non-small Cell Lung Cancer Chara Papadaki, Maria Sfakianaki, Georgios Ioannidis, Journal of Thoracic Oncology Pretreated PatientsSecond-line Cisplatin-based ChemotherapyMedicinePathologyBronchial Neoplasm	2012	70
PKM2 as a biomarker for chemosensitivity to front-line platinum-based chemotherapy in patients with metastatic non-small-cell lung cancer Chara Papadaki, Maria Sfakianaki, Eleni Lagoudaki, British Journal of Cancer	2014	58
BRAFV600E Mutation Analysis in Patients with Metastatic Colorectal Cancer (mCRC) in Daily Clinical Practice: Correlations with Clinical Characteristics, and Its Impact on Patients’ Outcome Zacharenia Saridaki, Maria Tzardi, Maria Sfakianaki, PLoS ONE	2013	55
Circulating miRNAs as a marker of metastatic disease and prognostic factor in metastatic breast cancer Chara Papadaki, Giannis Stoupis, Leuteris Tsalikis, Oncotarget	2019	47
Correlation of PKM2 and CD44 Protein Expression with Poor Prognosis in Platinum-Treated Epithelial Ovarian Cancer: A Retrospective Study Chara Papadaki, Stavroula D Manolakou, Eleni Lagoudaki, Cancers	2020	45
Regional distribution and cell type-specific expression of the mouse F3 axonal glycoprotein: A developmental study Daniela Virgintino, Margherita Ambrosini, Patrizia D'Errico, The Journal of Comparative Neurology	1999	44

Page 1